Graves Adrienne L

DirectorIVERIC bio, Inc. (ISEE) · full profile →Form 4 · filed Jul 13, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
1 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 11, 2023Disposed to issuer(D)22K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 11, 2023Disposed to issuer(D)23K0
Jul 11, 2023Disposed to issuer(D)8K0
Jul 11, 2023Disposed to issuer(D)16K0
Jul 11, 2023Disposed to issuer(D)32K0
Jul 11, 2023Disposed to issuer(D)16K0
Jul 11, 2023Disposed to issuer(D)16K0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-080688) within minutes of acceptance. Every field above traces to the original document. Verify it directly: